Patents by Inventor SHIVAKUMAR PRADEEP
SHIVAKUMAR PRADEEP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11857680Abstract: The present invention relates to a pharmaceutical liposomal composition comprising of about 0.8% w/w to about 1% w/w of docetaxel, about 30% w/w to about 38% w/w of Soya Phosphatidyl Choline, about 0.2% w/w to about 0.8% w/w of Sodium Cholesteryl Sulfate, about 61% w/w to about 68% w/w of Sucrose and a pH adjusting agent, wherein the pH of liposomal composition is less than 3.5 and the process for preparation thereof.Type: GrantFiled: October 19, 2020Date of Patent: January 2, 2024Assignee: SHILPA MEDICARE LIMITEDInventors: Kiran K Jadhav, Prashanth S, Shivakumar Pradeep, Sreenivasa Reddy
-
Patent number: 11857556Abstract: The present invention relates to a composition for topical application for preventing hair loss, androgenic alopecia (AA) and stimulating hair growth having dutasteride. The composition for topical application for preventing hair loss and stimulating hair growth according to the present invention provides equal or superior hair loss prevention and hair growth stimulating effects while using much smaller dosage than the conventional compositions (oral dosage form) which use finasteride and dutasteride.Type: GrantFiled: April 26, 2021Date of Patent: January 2, 2024Assignee: SHILPA MEDICARE LIMITEDInventors: Rajendar Medishetty, Agadihiremath Thippeswamy, Sreenivasa Reddy, Shivakumar Pradeep
-
Publication number: 20220347191Abstract: The present invention relates to a composition for topical application for preventing hair loss, androgenic alopecia (AA) and stimulating hair growth having dutasteride. The composition for topical application for preventing hair loss and stimulating hair growth according to the present invention provides equal or superior hair loss prevention and hair growth stimulating effects while using much smaller dosage than the conventional compositions (oral dosage form) which use finasteride and dutasteride.Type: ApplicationFiled: April 26, 2021Publication date: November 3, 2022Inventors: RAJENDAR MEDISHETTY, AGADIHIREMATH THIPPESWAMY, SREENIVASA REDDY, SHIVAKUMAR PRADEEP
-
Publication number: 20220257613Abstract: The present invention relates to a dispersible tablet comprising at least 70% w/w of abiraterone acetate based on the total weight of the tablet and at least one pharmaceutically excipient selected from group consisting of diluents, binders, surfactants, glidants, disintegrants, lubricants, sweeteners and flavorants and further relates to the process for the preparation thereof.Type: ApplicationFiled: July 2, 2020Publication date: August 18, 2022Applicant: SHILPA MEDICARE LTDInventors: NIJAGUNI REVANSIDDAYYA RUDRASWAMY MATH, SREENIVASA REDDY, RAVI VAMSI PERI, SHIVAKUMAR PRADEEP
-
Publication number: 20220117892Abstract: The present invention relates to a pharmaceutical liposomal composition comprising of about 0.8% w/w to about 1% w/w of docetaxel, about 30% w/w to about 38% w/w of Soya Phosphatidyl Choline, about 0.2% w/w to about 0.8% w/w of Sodium Cholesteryl Sulfate, about 61% w/w to about 68% w/w of Sucrose and a pH adjusting agent, wherein the pH of liposomal composition is less than 3.5 and the process for preparation thereof.Type: ApplicationFiled: October 19, 2020Publication date: April 21, 2022Applicant: SHILPA MEDICARE LTDInventors: KIRAN K JADHAV, PRASHANTH S, SHIVAKUMAR PRADEEP, SREENIVASA REDDY
-
Patent number: 11298360Abstract: The present invention relates to an aqueous ophthalmic solution for treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma, the solution comprising at least 0.5 w/v % brinzolamide dissolved in the solution; hydroxy-propyl-?-cyclodextrin; polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer; and water and/or the process for preparation thereof.Type: GrantFiled: April 2, 2019Date of Patent: April 12, 2022Inventors: Saraganachari Andanayya, Narayanaswamy Abhilash, Sreenivasa Reddy, Shivakumar Pradeep
-
Publication number: 20210353635Abstract: The present invention relates to an aqueous ophthalmic solution for treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma, the solution comprising at least 0.5 w/v % brinzolamide dissolved in the solution; hydroxy-propyl-?-cyclodextrin; polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer; and water and/or the process for preparation thereof.Type: ApplicationFiled: April 2, 2019Publication date: November 18, 2021Applicant: SHILPA MEDICARE LTDInventors: SARAGANACHARI ANDANAYYA, NARAYANASWAMY ABHILASH, SREENIVASA REDDY, SHIVAKUMAR PRADEEP
-
Publication number: 20210186862Abstract: The present invention relates to a topical pharmaceutical composition containing of about 0.01% w/w to about 0.1% w/w of methotrexate in topical solution form for external use for the treatment of psoriasis. The present invention also further encompasses the process for the preparation of the methotrexate in topical solution form.Type: ApplicationFiled: December 4, 2018Publication date: June 24, 2021Applicant: SHILPA MEDICARE LTDInventors: MOHAN KUMAR BHANDARI, SREENIVASA REDDY, SHIVAKUMAR PRADEEP, THIPPESWAMY AGADIHIREMATH
-
Patent number: 10993934Abstract: The present invention relates to a composition for topical application for preventing hair loss, androgenic alopecia (AA) and stimulating hair growth having dutasteride. The composition for topical application for preventing hair loss and stimulating hair growth according to the present invention provides equal or superior hair loss prevention and hair growth stimulating effects while using much smaller dosage than the conventional compositions (oral dosage form) which use finasteride and dutasteride.Type: GrantFiled: June 18, 2018Date of Patent: May 4, 2021Assignee: SHILPA MEDICARE LIMITEDInventors: Rajendar Medishetty, Agadihiremath Thippeswamy, Sreenivasa Reddy, Shivakumar Pradeep
-
Patent number: 10842771Abstract: The present invention relates to a pharmaceutical liposomal composition comprising of about 0.8% w/w to about 1% w/w of docetaxel, about 30% w/w to about 38% w/w of Soya Phosphatidyl Choline, about 0.2% w/w to about 0.8% w/w of Sodium Cholesteryl Sulfate, about 61% w/w to about 68% w/w of Sucrose and a pH adjusting agent, wherein the pH of liposomal composition is less than 3.5 and the process for preparation thereof.Type: GrantFiled: November 26, 2018Date of Patent: November 24, 2020Assignee: SHILPA MEDICARE LIMITEDInventors: Kiran K Jadhav, Prashanth S, Shivakumar Pradeep, Sreenivasa Reddy
-
Publication number: 20200281888Abstract: The present invention relates to a pharmaceutical liposomal composition comprising of about 0.8% w/w to about 1% w/w of docetaxel, about 30% w/w to about 38% w/w of Soya Phosphatidyl Choline, about 0.2% w/w to about 0.8% w/w of Sodium Cholesteryl Sulfate, about 61% w/w to about 68% w/w of Sucrose and a pH adjusting agent, wherein the pH of liposomal composition is less than 3.5 and the process for preparation thereof.Type: ApplicationFiled: November 26, 2018Publication date: September 10, 2020Applicant: SHILPA MEDICARE LTDInventors: KIRAN K JADHAV, PRASHANTH S, SHIVAKUMAR PRADEEP, SREENIVASA REDDY
-
Publication number: 20200237732Abstract: The present invention relates to a composition for topical application for preventing hair loss, androgenic alopecia (AA) and stimulating hair growth having dutasteride. The composition for topical application for preventing hair loss and stimulating hair growth according to the present invention provides equal or superior hair loss prevention and hair growth stimulating effects while using much smaller dosage than the conventional compositions (oral dosage form) which use finasteride and dutasteride.Type: ApplicationFiled: June 18, 2018Publication date: July 30, 2020Applicant: SHILPA MEDICARE LTDInventors: RAJENDAR MEDISHETTY, AGADIHIREMATH THIPPESWAMY, SREENIVASA REDDY, SHIVAKUMAR PRADEEP
-
Patent number: 10722498Abstract: The present invention provides a stable, ophthalmic aqueous composition for topical administration comprising acetazolamide and an aqueous liquid capable of forming a pharmaceutically acceptable gel in situ when applied topically to a patient, said composition has the pH of less than 4.5.Type: GrantFiled: January 22, 2018Date of Patent: July 28, 2020Assignee: SHILPA MEDICARE LIMITEDInventors: Andanayya Saraganachari, Abhilash Narayanaswamy, Sreenivasa Reddy, Shivakumar Pradeep
-
Patent number: 10682326Abstract: The present invention relates to a stable, non-aqueous liquid, formulation consisting essentially of melphalan, or a pharmaceutical acceptable salt thereof; and one or more solvents selected from group consisting of dimethyl acetamide, polyethylene glycol, ethanol, propylene glycol, dimethyl sulfoxide, N-methylpyrrolidone and glycerol; wherein said formulation is free of antioxidants, organic acid and added chloride ions; and the process for preparation thereof.Type: GrantFiled: July 17, 2019Date of Patent: June 16, 2020Assignee: SHILPA MEDICARE LIMITEDInventors: Shivakumar Pradeep, Krishnamurthy Toppaladoddi, Rizwan Ahmed, Guptha Chinni Guru Deva, Nagaraju Dasari
-
Patent number: 10583133Abstract: The present invention relates to a pharmaceutical composition comprising lenvatinib mesylate and a stabilizer in an amount of about 10% to about 20% based on the total weight of the composition, wherein the stabilizer is selected from the group consisting of calcium hydroxide and potassium hydroxide; and its process for preparation thereof.Type: GrantFiled: March 1, 2019Date of Patent: March 10, 2020Assignee: SHILPA MEDICARE LIMITEDInventors: Nijaguni Revansiddayya Rudraswamy Math, Sreenivas Reddy, Ravi Vamsi Peri, Krishnamurthy Toppaladoddi, Shivakumar Pradeep
-
Publication number: 20200054612Abstract: The present invention provides a stable, ophthalmic aqueous composition for topical administration comprising acetazolamide and an aqueous liquid capable of forming a pharmaceutically acceptable gel in situ when applied topically to a patient, said composition has the pH of less than 4.5.Type: ApplicationFiled: January 22, 2018Publication date: February 20, 2020Applicant: SHILPA MEDICARE LTDInventors: ANDANAYYA SARAGANACHARI, ABHILASH NARAYANASWAMY, SREENIVASA REDDY, SHIVAKUMAR PRADEEP
-
Publication number: 20190275026Abstract: The present invention relates to a pharmaceutical composition comprising lenvatinib mesylate and a stabilizer in an amount of about 10% to about 20% based on the total weight of the composition, wherein the stabilizer is selected from the group consisting of calcium hydroxide and potassium hydroxide; and its process for preparation thereof.Type: ApplicationFiled: March 1, 2019Publication date: September 12, 2019Applicant: SHILPA MEDICARE LTDInventors: NIJAGUNI REVANSIDDAYYA RUDRASWAMY MATH, SREENIVAS REDDY, RAVI VAMSI PERI, KRISHNAMURTHY TOPPALADODDI, SHIVAKUMAR PRADEEP
